DK1950302T3 - Streptokok-antigener. - Google Patents
Streptokok-antigener.Info
- Publication number
- DK1950302T3 DK1950302T3 DK08155317.4T DK08155317T DK1950302T3 DK 1950302 T3 DK1950302 T3 DK 1950302T3 DK 08155317 T DK08155317 T DK 08155317T DK 1950302 T3 DK1950302 T3 DK 1950302T3
- Authority
- DK
- Denmark
- Prior art keywords
- streptococcal antigens
- streptococcal
- antigens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11380098P | 1998-12-23 | 1998-12-23 | |
EP99960748A EP1141306B1 (en) | 1998-12-23 | 1999-12-20 | Streptococcus antigens |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1950302T3 true DK1950302T3 (da) | 2013-01-14 |
Family
ID=22351610
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08155317.4T DK1950302T3 (da) | 1998-12-23 | 1999-12-20 | Streptokok-antigener. |
DK99960748T DK1141306T3 (da) | 1998-12-23 | 1999-12-20 | Streptococcus-antigener |
DK10180372.4T DK2261358T3 (da) | 1998-12-23 | 1999-12-20 | Nyt streptococcus-antigen |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99960748T DK1141306T3 (da) | 1998-12-23 | 1999-12-20 | Streptococcus-antigener |
DK10180372.4T DK2261358T3 (da) | 1998-12-23 | 1999-12-20 | Nyt streptococcus-antigen |
Country Status (30)
Country | Link |
---|---|
EP (2) | EP1141306B1 (da) |
JP (2) | JP4761623B2 (da) |
KR (4) | KR101170203B1 (da) |
CN (3) | CN101134775A (da) |
AP (1) | AP2001002199A0 (da) |
AR (1) | AR029322A1 (da) |
AT (1) | ATE394489T1 (da) |
AU (1) | AU1764900A (da) |
BR (1) | BR9916477A (da) |
CA (1) | CA2356836C (da) |
CL (1) | CL2009002037A1 (da) |
CY (3) | CY1108223T1 (da) |
CZ (2) | CZ302790B6 (da) |
DE (1) | DE69938670D1 (da) |
DK (3) | DK1950302T3 (da) |
EA (1) | EA007409B1 (da) |
ES (3) | ES2306528T3 (da) |
HK (1) | HK1118575A1 (da) |
HU (1) | HU229664B1 (da) |
IL (3) | IL143905A0 (da) |
MX (1) | MXPA01006427A (da) |
NO (1) | NO330800B1 (da) |
NZ (1) | NZ512574A (da) |
OA (1) | OA11736A (da) |
PL (3) | PL204073B1 (da) |
PT (3) | PT1141306E (da) |
TR (2) | TR200200633T2 (da) |
UY (1) | UY25877A1 (da) |
WO (1) | WO2000039299A2 (da) |
ZA (1) | ZA200105114B (da) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100771148B1 (ko) | 1998-02-20 | 2007-10-29 | 아이디 바이오메디칼 코포레이션 | 그룹 b 스트렙토코커스 항원 |
US20030134407A1 (en) | 1998-07-27 | 2003-07-17 | Le Page Richard William Falla | Nucleic acids and proteins from Streptococcus pneumoniae |
EP1801218A3 (en) * | 1998-07-27 | 2007-10-10 | Sanofi Pasteur Limited | Nucleic acids and proteins from streptococcus pneumoniae |
DE69940439D1 (de) | 1998-12-21 | 2009-04-02 | Medimmune Inc | Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe |
US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
KR101170203B1 (ko) * | 1998-12-23 | 2012-07-31 | 아이디 바이오메디칼 코포레이션 | 신규한 스트렙토코커스 항원 |
US6866855B2 (en) | 2000-06-12 | 2005-03-15 | University Of Saskatchewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
US6833134B2 (en) | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
US6660270B2 (en) * | 2000-06-12 | 2003-12-09 | University Of Saskatchewan | Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection |
CN101260149B (zh) | 2000-06-20 | 2016-05-11 | 魁北克益得生物医学公司 | 链球菌抗原 |
US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
AU2002242549A1 (en) * | 2001-03-30 | 2002-10-15 | Shire Biochem Inc. | Streptococcus pyogenes antigens and corresponding dna fragments |
US7393536B2 (en) | 2001-07-06 | 2008-07-01 | Id Biomedical Corporation | Group B Streptococcus antigens and corresponding DNA fragments |
GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
EP1456231A2 (en) | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Streptococcus antigens |
EP2287311A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
US7635487B2 (en) | 2003-04-15 | 2009-12-22 | Intercell Ag | S. pneumoniae antigens |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
EA014107B1 (ru) | 2005-12-22 | 2010-10-29 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
PT2167121E (pt) | 2007-06-26 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae |
ES2397488T3 (es) * | 2007-07-23 | 2013-03-07 | Sanofi Pasteur Limited | Polipéptidos inmunógenos y anticuerpos monoclonales |
ES2553113T3 (es) * | 2008-04-16 | 2015-12-04 | Glaxosmithkline Biologicals S.A. | Vacuna |
EP2349209A2 (en) | 2008-09-26 | 2011-08-03 | Nanobio Corporation | Nanoemulsion therapeutic compositions and methods of using the same |
WO2010125480A1 (en) | 2009-04-30 | 2010-11-04 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
WO2010132833A1 (en) | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
ES2670576T3 (es) | 2009-09-03 | 2018-05-31 | Pfizer Vaccines Llc | Vacuna de PCSK9 |
GB201003920D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
MX2013006255A (es) | 2010-12-03 | 2015-08-05 | Sanofi Pasteur Ltd | Composicion para inmunizacion contra streptococcus pneumoniae. |
AU2012207089B2 (en) * | 2011-01-20 | 2016-04-14 | Children's Medical Center Corporation | Vaccines and compositions against Streptococcus pneumoniae |
US20140004142A1 (en) | 2011-03-02 | 2014-01-02 | Pfizer Inc. | Pcsk9 vaccine |
JP2014515035A (ja) | 2011-05-17 | 2014-06-26 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ストレプトコッカス・ニューモニエに対するワクチン |
JP6316755B2 (ja) * | 2012-01-05 | 2018-04-25 | ドイチェス クレープスフォルシュングスツェントルムDeutsches Krebsforschungszentrum | Idh1r132h変異陽性がんを治療または診断する手段および方法 |
EP2931743A4 (en) * | 2012-12-14 | 2016-08-03 | Sanofi Pasteur Ltd | METHOD FOR ASSESSING IMMUNOGENICITY |
US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
RU2771293C2 (ru) | 2014-01-21 | 2022-04-29 | Пфайзер Инк. | Иммуногенные композиции, содержащие конъюгированные капсульные сахаридные антигены, и их применение |
PL3096783T3 (pl) | 2014-01-21 | 2021-12-13 | Pfizer Inc. | Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty |
MX371453B (es) | 2014-01-21 | 2020-01-29 | Pfizer | Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos. |
JP2017505792A (ja) | 2014-02-14 | 2017-02-23 | ファイザー・インク | 免疫原性糖タンパク質コンジュゲート |
MX2017009308A (es) | 2015-01-15 | 2017-11-08 | Pfizer | Composiciones inmunogenicas para usar en vacunas neumococicas. |
TWI720448B (zh) | 2015-07-21 | 2021-03-01 | 美商輝瑞股份有限公司 | 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途 |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
WO2017085586A1 (en) | 2015-11-20 | 2017-05-26 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
BR112019014833A2 (pt) | 2017-01-20 | 2020-04-14 | Pfizer | composições imunogênicas para uso em vacinas pneumococais |
US11260119B2 (en) | 2018-08-24 | 2022-03-01 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
WO2020121159A1 (en) | 2018-12-12 | 2020-06-18 | Pfizer Inc. | Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof |
JP7239509B6 (ja) | 2019-02-22 | 2023-03-28 | ファイザー・インク | 細菌多糖類を精製するための方法 |
EP3952906A1 (en) | 2019-04-10 | 2022-02-16 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof |
JP2022542316A (ja) | 2019-07-31 | 2022-09-30 | サノフィ パスツール インコーポレイテッド | 多価肺炎球菌多糖体-タンパク質コンジュゲート組成物およびその使用方法 |
CN114667343A (zh) | 2019-11-01 | 2022-06-24 | 辉瑞大药厂 | 大肠杆菌组合物及其方法 |
CA3171864A1 (en) | 2020-02-21 | 2021-08-26 | Pfizer Inc. | Purification of saccharides |
PE20230170A1 (es) | 2020-02-23 | 2023-02-01 | Pfizer | Composiciones de escherichia coli y sus metodos |
EP4232593A1 (en) | 2020-10-22 | 2023-08-30 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
MX2023004912A (es) | 2020-10-27 | 2023-05-16 | Pfizer | Composiciones de escherichia coli y metodos de las mismas. |
US12138302B2 (en) | 2020-10-27 | 2024-11-12 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
CA3200602A1 (en) | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
US20220202923A1 (en) | 2020-12-23 | 2022-06-30 | Pfizer Inc. | E. coli fimh mutants and uses thereof |
WO2022234416A1 (en) | 2021-05-03 | 2022-11-10 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
EP4333879A1 (en) | 2021-05-03 | 2024-03-13 | Pfizer Inc. | Vaccination against bacterial and betacoronavirus infections |
JP2024521847A (ja) | 2021-05-28 | 2024-06-04 | ファイザー・インク | コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用 |
PH12023553205A1 (en) | 2021-05-28 | 2024-02-19 | Pfizer | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
EP4463186A1 (en) | 2022-01-13 | 2024-11-20 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2023161817A1 (en) | 2022-02-25 | 2023-08-31 | Pfizer Inc. | Methods for incorporating azido groups in bacterial capsular polysaccharides |
KR20250008122A (ko) | 2022-05-11 | 2025-01-14 | 화이자 인코포레이티드 | 보존제를 갖는 백신 제형의 제조 방법 |
WO2024084397A1 (en) | 2022-10-19 | 2024-04-25 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
WO2024110827A1 (en) | 2022-11-21 | 2024-05-30 | Pfizer Inc. | Methods for preparing conjugated capsular saccharide antigens and uses thereof |
US20240181028A1 (en) | 2022-11-22 | 2024-06-06 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024116096A1 (en) | 2022-12-01 | 2024-06-06 | Pfizer Inc. | Pneumococcal conjugate vaccine formulations |
WO2024166008A1 (en) | 2023-02-10 | 2024-08-15 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024201324A2 (en) | 2023-03-30 | 2024-10-03 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024214016A1 (en) | 2023-04-14 | 2024-10-17 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024224266A1 (en) | 2023-04-24 | 2024-10-31 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024241172A2 (en) | 2023-05-19 | 2024-11-28 | Glaxosmithkline Biologicals Sa | Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection |
WO2025057078A1 (en) | 2023-09-14 | 2025-03-20 | Pfizer Inc. | Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antigens and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
CN1046291C (zh) * | 1993-03-19 | 1999-11-10 | G·林达尔 | Rib蛋白、其纯化方法、检测试剂盒及药物组合物 |
JPH11507214A (ja) * | 1995-06-07 | 1999-06-29 | バイオケム ヴァシーンズ インク. | Hsp70ファミリーに属する連鎖球菌の熱ショック蛋白質メンバー |
US5928895A (en) * | 1996-09-24 | 1999-07-27 | Smithkline Beecham Corporation | IgA Fc binding protein |
US5882896A (en) * | 1996-09-24 | 1999-03-16 | Smithkline Beecham Corporation | M protein |
ES2277362T5 (es) * | 1996-10-31 | 2014-12-18 | Human Genome Sciences, Inc. | Antígenos y vacunas de streptococcus pneumoniae |
AU9510598A (en) * | 1997-09-24 | 1999-04-12 | American Cyanamid Company | Human complement c3-degrading proteinase from (streptococcus pneumoniae) |
AU770378B2 (en) * | 1998-04-23 | 2004-02-19 | Uab Research Foundation | Pneumococcal surface protein C(PspC), epitopic regions and strain selection thereof, and uses therefor |
EP1144640A3 (en) * | 1998-07-27 | 2001-11-28 | Microbial Technics Limited | Nucleic acids and proteins from streptococcus pneumoniae |
DE69935986D1 (de) * | 1998-07-27 | 2007-06-14 | Sanofi Pasteur Ltd | Streptococcus pneumoniae proteine und nukleinsäuren |
JP2002526082A (ja) * | 1998-09-24 | 2002-08-20 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ストレプトコッカス・ニューモニア由来のヒト補体c3分解ポリペプチド |
DE69940439D1 (de) * | 1998-12-21 | 2009-04-02 | Medimmune Inc | Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe |
KR101170203B1 (ko) * | 1998-12-23 | 2012-07-31 | 아이디 바이오메디칼 코포레이션 | 신규한 스트렙토코커스 항원 |
-
1999
- 1999-12-20 KR KR1020087008264A patent/KR101170203B1/ko not_active IP Right Cessation
- 1999-12-20 CN CNA2007101481600A patent/CN101134775A/zh active Pending
- 1999-12-20 OA OA1200100165A patent/OA11736A/en unknown
- 1999-12-20 PL PL382438A patent/PL204073B1/pl not_active IP Right Cessation
- 1999-12-20 PL PL382437A patent/PL205041B1/pl unknown
- 1999-12-20 ES ES99960748T patent/ES2306528T3/es not_active Expired - Lifetime
- 1999-12-20 PT PT99960748T patent/PT1141306E/pt unknown
- 1999-12-20 HU HU0104774A patent/HU229664B1/hu not_active IP Right Cessation
- 1999-12-20 BR BR9916477-9A patent/BR9916477A/pt active Search and Examination
- 1999-12-20 MX MXPA01006427A patent/MXPA01006427A/es not_active IP Right Cessation
- 1999-12-20 CN CNB2005100037492A patent/CN100398653C/zh not_active Expired - Fee Related
- 1999-12-20 JP JP2000591190A patent/JP4761623B2/ja not_active Expired - Fee Related
- 1999-12-20 CZ CZ20100674A patent/CZ302790B6/cs not_active IP Right Cessation
- 1999-12-20 CA CA2356836A patent/CA2356836C/en not_active Expired - Fee Related
- 1999-12-20 TR TR2002/00633T patent/TR200200633T2/xx unknown
- 1999-12-20 EP EP99960748A patent/EP1141306B1/en not_active Expired - Lifetime
- 1999-12-20 CZ CZ20012161A patent/CZ303675B6/cs not_active IP Right Cessation
- 1999-12-20 PT PT101803724T patent/PT2261358E/pt unknown
- 1999-12-20 AT AT99960748T patent/ATE394489T1/de active
- 1999-12-20 DK DK08155317.4T patent/DK1950302T3/da active
- 1999-12-20 EP EP10180372.4A patent/EP2261358B1/en not_active Expired - Lifetime
- 1999-12-20 KR KR1020107009285A patent/KR101078919B1/ko not_active IP Right Cessation
- 1999-12-20 DK DK99960748T patent/DK1141306T3/da active
- 1999-12-20 WO PCT/CA1999/001218 patent/WO2000039299A2/en active Application Filing
- 1999-12-20 AU AU17649/00A patent/AU1764900A/en not_active Abandoned
- 1999-12-20 KR KR1020067025282A patent/KR100891398B1/ko not_active IP Right Cessation
- 1999-12-20 AP APAP/P/2001/002199A patent/AP2001002199A0/en unknown
- 1999-12-20 ES ES10180372.4T patent/ES2480417T3/es not_active Expired - Lifetime
- 1999-12-20 PL PL349777A patent/PL206576B1/pl unknown
- 1999-12-20 CN CNB998149047A patent/CN1191362C/zh not_active Expired - Fee Related
- 1999-12-20 KR KR1020017007963A patent/KR100802198B1/ko not_active IP Right Cessation
- 1999-12-20 PT PT81553174T patent/PT1950302E/pt unknown
- 1999-12-20 NZ NZ512574A patent/NZ512574A/xx not_active IP Right Cessation
- 1999-12-20 EA EA200100565A patent/EA007409B1/ru not_active IP Right Cessation
- 1999-12-20 ES ES08155317T patent/ES2400280T3/es not_active Expired - Lifetime
- 1999-12-20 IL IL14390599A patent/IL143905A0/xx unknown
- 1999-12-20 TR TR2001/02497T patent/TR200102497T2/xx unknown
- 1999-12-20 DK DK10180372.4T patent/DK2261358T3/da active
- 1999-12-20 DE DE69938670T patent/DE69938670D1/de not_active Expired - Lifetime
- 1999-12-23 AR ARP990106746A patent/AR029322A1/es not_active Application Discontinuation
- 1999-12-23 UY UY25877A patent/UY25877A1/es unknown
-
2001
- 2001-06-19 NO NO20013045A patent/NO330800B1/no not_active IP Right Cessation
- 2001-06-21 ZA ZA200105114A patent/ZA200105114B/en unknown
- 2001-06-21 IL IL143905A patent/IL143905A/en not_active IP Right Cessation
-
2008
- 2008-07-29 CY CY20081100787T patent/CY1108223T1/el unknown
- 2008-09-10 HK HK08110047.4A patent/HK1118575A1/xx not_active IP Right Cessation
- 2008-09-21 IL IL194230A patent/IL194230A/en not_active IP Right Cessation
-
2009
- 2009-11-05 CL CL2009002037A patent/CL2009002037A1/es unknown
-
2010
- 2010-02-09 JP JP2010026521A patent/JP5039802B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-27 CY CY20121101268T patent/CY1114722T1/el unknown
-
2014
- 2014-07-16 CY CY20141100536T patent/CY1115340T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1950302T3 (da) | Streptokok-antigener. | |
CU23049A3 (es) | Dihidropirimidinas. | |
TR199902372A3 (tr) | Sulfanilsilanlar. | |
NO20026121D0 (no) | Streptokokkantigener | |
NO20004161D0 (no) | Gruppe B streptokokkantigener | |
IT1312540B1 (it) | Composto. | |
IT1303546B1 (it) | Cerniera lampo. | |
NO20005141D0 (no) | Streptokokkpreparat | |
ES1036909Y (es) | Pupitre infantil. | |
ES1037395Y (es) | Tendedero antilluvia. | |
ITDP980002A1 (it) | Vedi descrizione. | |
ES1039730Y (es) | Rodapie. | |
ES1040343Y (es) | Carrito portafregona. | |
ES1040589Y (es) | Expositor-dispensador. | |
ES1040633Y (es) | Escalifono. | |
ES1040731Y (es) | Gafa. | |
ES1042117Y (es) | Mesa-sombrilla. | |
ITBO980260A1 (it) | Riavvolgicarta. | |
ITNA980067A1 (it) | Bloccatappo. | |
ES1040336Y (es) | Lingote mejorado. | |
ITDP980003A1 (it) | Nessuna. | |
ES1036948Y (es) | Carpeta-atril mejorada. | |
ES1038416Y (es) | Gregadero mejorado. | |
ES1036324Y (es) | Cose-papeles mejorado. | |
ITBO980286A0 (it) | Raccordo pneumatico. |